Purchase Order HHSN272201100823P
Award Date 9/7/11
Potential Completion Date 7/3/12
Potential Value $62K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $4,266.00, was awarded by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for the purchase of various Illumina sequencing systems, reagents, and related services. The contract is a firm fixed-price purchase order with no set-aside designation. Illumina has received...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $42,391 firm fixed price purchase order contract to Illumina, Inc. for service and support for Illumina's genome analyzer and cluster station equipment. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is valued at $13,613.60 and was awarded on September 8, 2014, with a completion date of October 5, 2014. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic sequencing and analysis equipment, has provided a range of sequencing systems, reagents, and...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $52,300 award is for the provision of a Genome Analyzer instrument and related service agreement, with a period of performance ending on April 10, 2015. There was no set-aside designation for this contract. Illumina has a history of providing...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $8,734 firm fixed-price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has no set-aside designation....
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), was issued to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $24,385.03 firm fixed price purchase order does not have a set-aside designation. The award supports Illumina's provision of goods and services related to genomic sequencing and analysis, potentially for research and...